binding-affinity prediction methods, and AI-accelerated virtual-screening platforms to identify and prioritize promising therapeutic leads.
We are seeking a highly motivated Post-Doctoral Fellow interested in developing and applying AI and physics-based computational methods for drug discovery. The successful candidate will have opportunities to pursue projects spanning AI model development, protein-ligand modeling, molecular docking and binding-affinity prediction, and large-scale virtual screening. The candidate will also have opportunities to work closely with experimental collaborators to apply newly developed computational methods to challenging therapeutic targets and experimentally validate computational predictions.
Candidates should be nearing completion of or already have a PhD in computational chemistry, biophysics, computer science, or a related field. Candidates should have a strong computational background and at least one first-author peer-reviewed publication. Experience in one or more of the following areas is desirable: machine learning/deep learning, molecular modeling, molecular dynamics, protein structure modeling, cheminformatics, or computational drug discovery. We particularly value candidates who are creative, self-motivated, and interested in developing new computational methods, while working collaboratively with computational and experimental researchers.
In addition to the online application, interested individuals should submit the following as a single PDF to Dr. Guangfeng Zhou (gzhou@wistar.org): (1) CV; (2) one-page cover letter detailing scientific interest in the lab, potential interest areas for research projects, and career aspirations; and (3) contact information for three references.
We offer a competitive salary and an excellent benefits package.
The Wistar Institute is in Philadelphia, in the heart of the University of Pennsylvania campus. Wistar provides resources for cutting-edge collaborative research and provides for outstanding intellectual environments and state-of-the-art facilities. The Wistar Institute is a world leader in early-stage discovery science in the areas of cancer, immunology, and infectious disease. Wistar is committed to accelerating research advances from bench to bedside through brilliant science and distinctive approaches to collaboration among scientific investigators and academic and industry partners. Wistar’s dynamic environment supports the advancement of discoveries that will change the future of human health.
For more information about The Wistar Institute visit our website at www.wistar.org.
